文献速递前列腺癌

局限性前列腺癌治疗与心理健康结局之间的关联

Association between Treatment for Localized Prostate Cancer and Mental Health Outcomes.
PubMed 文献 · J Urol · 2022-03-03

基于CEASAR前瞻性人群队列,纳入2,742例局限性前列腺癌男性,比较手术、放疗(联合或不联合雄激素剥夺治疗)与主动监测后5年内患者报告的抑郁症状、情绪健康和精力/疲劳。结果显示治疗方式与这些心理健康结局无临床重要差异,但年龄较大、健康状况较差、未婚和基线CES-D评分与心理健康下降相关。

要点

  • 治疗方式(手术、放疗或主动监测)对抑郁症状无影响(p=0.78)。
  • 治疗方式与情绪健康(p=0.81)或精力/疲劳(p=0.054)评分无临床重要关联。
  • 年龄较大、健康状况较差、未婚和基线CES-D评分与心理健康结局恶化相关。

核心结论

  • 这项前瞻性人群队列研究显示,局限性前列腺癌男性接受手术、放疗或监测后,心理健康结局包括抑郁症状、情绪健康和精力/疲劳无临床重要差异。
  • 年龄较大、健康状况较差、未婚和基线CES-D评分与较差的治疗心理健康结局相关,可能有助于早期识别风险患者。

研究设计与样本

  • 前瞻性人群分析,使用手术和放疗比较效果分析(CEASAR)研究。
  • 共纳入2,742例男性,中位年龄64岁(四分位数59-70)。
  • 通过5年随访评估患者报告的抑郁症状(流行病学研究中心抑郁量表[CES-D])以及医学结局研究36项简表调查中评估情绪健康和精力/疲劳的领域。
  • 治疗方式包括手术、放疗(联合或不联合雄激素剥夺治疗)和主动监测。
  • 回归模型针对结局特异性基线功能、人口学和临床病理特征以及治疗方式进行了调整。

主要发现

  • 基线CES-D测量的抑郁症状较低(中位数4,四分位数1-8),组间无差异。
  • 未发现治疗方式对抑郁症状的影响(p=0.78)。
  • 治疗方式与情绪健康评分(p=0.81)或精力/疲劳评分(p=0.054)无临床重要关联。
  • 年龄较大、健康状况较差、未婚和基线CES-D评分与心理健康下降相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We aimed to compare patient-reported mental health outcomes for men undergoing treatment for localized prostate cancer longitudinally over 5 years. MATERIALS AND METHODS: We conducted a prospective population-based analysis using the Comparative Effectiveness Analysis of Surgery and Radiation (CEASAR) study. Patient-reported depressive symptoms (Centers for Epidemiologic Studies Depression [CES-D]) and domains of the Medical Outcomes Study 36-item Short Form survey evaluating emotional well-being and energy/fatigue were assessed through 5 years after treatment with surgery, radiotherapy (with or without androgen deprivation therapy) and active surveillance. Regression models were adjusted for outcome-specific baseline function, demographic and clinicopathological characteristics, and treatment approach. RESULTS: A total of 2,742 men (median [quartiles] age 64 [59-70]) met inclusion criteria. Baseline depressive symptoms, as measured by the CES-D, were low (median 4, quartiles 1-8) without differences between groups. We found no effect of treatment modality on depressive symptoms (p=0.78), though older age, poorer health, being unmarried and baseline CES-D score were associated with declines in mental health. There was no clinically meaningful association between treatment modality and scores for either emotional well-being (p=0.81) or energy/fatigue (p=0.054). CONCLUSIONS: This prospective, population-based cohort study of men with localized prostate cancer showed no clinically important differences in mental health outcomes including depressive symptoms, emotional well-being, and energy/fatigue according to the treatment received (surgery, radiotherapy, or surveillance). However, we identified a number of characteristics associated with worse mental health outcomes including: older age, poorer health, being unmarried, and baseline CES-D score which may allow for early identification of patients most at risk of these outcomes following treatment.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Luckenbaugh AN, Wallis CJD, Huang LC, et al. Association between Treatment for Localized Prostate Cancer and Mental Health Outcomes. J Urol. 2022. PMID: 34978488. doi:10.1097/JU.0000000000002370

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。